Section Arrow
Quote
INDV.NASDAQ
- Indivior Pharmaceuticals Inc.
Quotes are at least 15-min delayed:2026/09/25 00:32 EDT
Regular Hours
Last
 36
+0.09 (+0.25%)
Day High 
36.28 
Prev. Close
35.91 
1-M High
36.9 
Volume 
2.22M 
Bid
35.06
Ask
36.3
Day Low
35.57 
Open
35.71 
1-M Low
33.74 
Market Cap 
4.24B 
Currency 美元 
P/E 12.87 
%Yield -- 
10-SMA 35.02 
20-SMA 34.98 
50-SMA 37.43 
52-W High 42.81 
52-W Low 22.5609 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.79/2.83
Enterprise Value
4.55B
Balance Sheet
Book Value Per Share
-1.75
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.19B
Operating Revenue Per Share
8.49
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
APUSApimeds Pharmaceuticals US Inc.4.92+2.63+114.85%-- 
HLNHaleon plc9.22+0.11+1.21%19PE
HIMSHims & Hers Health29.28+0.89+3.13%-- 
VTRSViatris17.42+0.3+1.75%-- 
TEVATeva Pharmaceutical Industries Limited40.22+1.21+3.10%65.02PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.